Prohost Letter #400

Prohost Letter #400

Prohost Letter #400 NEAR-­TERM INVESTING The Prohost Letter #399 Part 3 has Promised to Des
Senator Sanders and Ariad

Senator Sanders and Ariad

Shares of Ariad Pharmaceuticals declined following Senator Bernie Sanders’ criticism of the high price of the …
Exelixis: A Sunny Future

Exelixis: A Sunny Future

EXELIXIS APPROVED PRODUCTS 1. CABOMETYX™(CABOZANTINIB) For Exelixis (EXEL) the two approved oncology products cabozantinib and cobimetinib …